These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9195221

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity.
    Blackburn RV, Galoforo SS, Corry PM, Lee YJ.
    Int J Cancer; 1999 Jul 19; 82(2):293-7. PubMed ID: 10389766
    [Abstract] [Full Text] [Related]

  • 23. Adenovirus-mediated tissue-specific cytosine deaminase gene therapy for human hepatocellular carcinoma with different AFP expression levels.
    Huang X, Zhang W, Wakimoto H, Hamada H, Cao X.
    J Exp Ther Oncol; 2002 Jul 19; 2(2):100-6. PubMed ID: 12415626
    [Abstract] [Full Text] [Related]

  • 24. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma.
    Kaliberov SA, Market JM, Gillespie GY, Krendelchtchikova V, Della Manna D, Sellers JC, Kaliberova LN, Black ME, Buchsbaum DJ.
    Gene Ther; 2007 Jul 19; 14(14):1111-9. PubMed ID: 17495948
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Anticancer effects of cytosine deaminase gene/5-fluorocytosine therapies to ovarian cancer in vivo].
    Yao Y, Peng Z, Wang H, Li Q, Liu S.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Apr 19; 37(4):195-7. PubMed ID: 12133407
    [Abstract] [Full Text] [Related]

  • 31. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR, Williams CR, Buchsbaum DJ, Gillespie GY.
    Cancer Res; 2002 Feb 01; 62(3):773-80. PubMed ID: 11830532
    [Abstract] [Full Text] [Related]

  • 32. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus.
    Ichikawa T, Tamiya T, Adachi Y, Ono Y, Matsumoto K, Furuta T, Yoshida Y, Hamada H, Ohmoto T.
    Cancer Gene Ther; 2000 Jan 01; 7(1):74-82. PubMed ID: 10678359
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
    Rogers RP, Ge JQ, Holley-Guthrie E, Hoganson DK, Comstock KE, Olsen JC, Kenney S.
    Hum Gene Ther; 1996 Dec 01; 7(18):2235-45. PubMed ID: 8953314
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
    Cunningham C, Nemunaitis J.
    Hum Gene Ther; 2001 Aug 10; 12(12):1594-6. PubMed ID: 11529249
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. 5-Fluorocytosine increases the toxicity of Wnt-targeting replicating adenoviruses that express cytosine deaminase as a late gene.
    Fuerer C, Iggo R.
    Gene Ther; 2004 Jan 10; 11(2):142-51. PubMed ID: 14712298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.